DongKook Pharmaceutical Co., Ltd. (086450.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	979.6B	926.9B	812.2B	731.0B	661.6B
Cost of Revenue	442.8B	425.3B	364.3B	326.0B	286.5B
Gross Profit	536.8B	501.6B	447.9B	405.0B	375.2B
Operating Expenses
R&D Expense	35.2B	32.8B	30.3B	25.5B	21.8B
SG&A Expense	325.5B	273.5B	250.9B	311.2B	207.7B
General & Admin Expense	10.3B	13.8B	15.3B	13.9B	12.3B
Selling & Marketing Expense	208.8B	259.7B	235.6B	225.4B	195.4B
Other Expenses	73.6B	98.8B	86.3B	1.5B	73.5B
Total Operating Expenses	434.3B	405.1B	367.5B	338.2B	302.9B
Cost and Expenses	877.1B	830.4B	731.7B	664.1B	589.4B
Operating Income (EBIT)	102.4B	96.5B	80.4B	66.9B	73.9B
Non-Operating
Interest Income	15.9B	16.3B	6.3B	5.3B	2.9B
Interest Expense	18.5B	18.6B	4.5B	5.9B	4.3B
Net Interest Income	(2.5B)	(2.3B)	1.8B	(613.2M)	(1.5B)
Other Non-Op Income/Expense	(2.4B)	(3.9B)	4.3B	(6.0B)	(5.3B)
Non-Operating Income (excl Interest)	6.1B	—	(8.8B)	(728.8M)	424.0M
EBT (Pre-Tax Income)	100.1B	92.6B	84.7B	60.8B	68.6B
Income Tax Expense	18.6B	18.7B	22.4B	12.0B	13.9B
Bottom Line
Net Income	76.3B	66.0B	61.2B	47.2B	52.9B
Earnings from Cont. Ops	81.5B	73.9B	62.3B	48.9B	54.8B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	76.3B	66.0B	60.8B	47.2B	52.9B
Per Share
Basic EPS	₩1,699	₩1,487	₩1,383	₩1,064	₩1,203
Diluted EPS	₩1,697	₩1,475	₩1,367	₩1,055	₩1,183
Revenue Per Share	₩21,715	₩20,877	₩18,472	₩16,628	₩15,054
Shares
Basic Shares Outstanding	45.1M	44.4M	44.0M	44.0M	44.0M
Diluted Shares Outstanding	45.1M	44.8M	44.7M	44.7M	44.7M
Profitability Metrics
EBITDA	135.7B	128.0B	115.0B	88.7B	91.0B
D&A	33.3B	31.5B	28.5B	21.1B	19.2B
EBIT	102.4B	96.5B	86.7B	67.6B	71.8B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026